Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ENSC US Equity

Ensysce Biosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1716947 · FY ends Dec 31
$0.39
+0.00 (+0.78%)
USD · as of 2026-08-19 · marketstack
4 8-K filings · 1 13D · 0 13G
DateEventWhat happened / filerSource
2026-08-1813D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by GOWER BOB Gsec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-068-K 9.01Financial statements and exhibits (amendment)sec.gov ↗
2026-08-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-068-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-08-068-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-068-K 3.03Material modification to rights of security holderssec.gov ↗
2026-08-068-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-068-K 2.01Completion of acquisition or disposition of assetssec.gov ↗
2026-08-068-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-158-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-15

Every row is a filed document, checked against its EDGAR index.